Replies to post #446722 on NorthWest Biotherapeutics Inc (NWBO)

[Bob_LobLaw]

Why aren’t we seeking regulatory approvals based on CRL’s manufacturing capacity and expertise? Why did we have to focus on so much development of Advent which has supposedly held up advancement. I think many of us know the answer. Toucan is priority #1. If we give LP enough slack she will open up a 3rd manufacturer, direct NWBO money to develop and we sit and wait for Toucan’s value grows while we languish and most unfortunately patients wait and wait and wait.

[Survivor2012]

Thx Doc logic. So, the "first patient treated" language in PR is prescient?!?!